It's a year since the Barton House tower block in east Bristol was evacuated. Priyanka Raval discusses residents' enduring ...

Shares in AbbVie slumped by double digits Monday after the company disclosed its psychiatric medicine emraclidine didn’t best ...

Meanwhile, shares of Bristol Myers Squibb, makers of recently approved schizophrenia treatment Cobenfy, soared 12%. Shares of AbbVie (ABBV) plummeted Monday after the company said its schizophrenia ...

Stocks rose to new record highs in early trading Monday, while bitcoin hit all-time highs of its own above $84,000, as the election-fueled rally continues.

Bristol Police are investigating a crash that killed a pedestrian Sunday evening. The accident happened around 6 p.m. Sunday ...

Council tax in Bristol could rise by an unprecedented 15 percent under City Hall proposals. The POSSIBLE 15% rise is three ...

BBC Radio Bristol's Sound of the City looks back at Bristol Academy's win against Barcelona in the Champions League in 2014.

AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.

BRISTOL, Conn. — Bristol police are investigating a fatal crash involving a pedestrian Sunday night, according to the city's police department. Based on a preliminary investigation, the Bristol Police ...

A partnership between Pennsylvania-based developer Benchmark Real Estate and New York-based investment firm Regal Ventures ...

Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.

Bristol-Myers Squibb's Cobenfy comes out as the major beneficiary and will extend its leadership in the muscarinic drug class ...